Tetratherix Ltd.
Limited financial coverage for TTX.AX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Established in 2015 and headquartered in Alexandria, Australia, Tetratherix Ltd. operates in the biomaterials and regenerative medicine sectors across both domestic and international markets. The company develops and supplies products using its proprietary Tetramatrix platform technology, with a focus on applications including bone regeneration, tissue spacing, and advanced tissue healing.
- CEO
- William Anthony Knox
- IPO
- 2025
- Employees
- 15
- HQ
- Alexandria, NSW, AU
Get TickerSpark's AI analysis on TTX.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $8.08
- 52W Low
- $3.09
- 50D MA
- $6.57
- 200D MA
- $4.90
- Beta
- 1.79
- RSI (14)
- 41
- Avg Volume
- 23.41K
No earnings-call transcripts are available for TTX.AX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 53.04M
- Float Shares
- 14.18K
Our TTX.AX coverage
Recent articles, reports, and earnings notes.
No research on TTX.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TTX.AX report →